The move comes just over a week after rival Eli Lilly cut the price for vials of its weight-loss drug Zepbound by $50 or more and expanded the range of doses sold online through its direct-to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback